Brief: Clearpoint Neuro Announces FDA Clearance For Clearpoint Prism Neuro Laser Therapy System
Sept 23 (Reuters) - Clearpoint Neuro Inc CLPT.O :
* CLEARPOINT NEURO ANNOUNCES FDA CLEARANCE FOR CLEARPOINT
PRISM™
NEURO LASER THERAPY SYSTEM
Source text for Eikon: ID:nGNX5lkhyv
Further company coverage: CLPT.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Clinical Laserthermia Systems AB
See all newsBrief: Clinical Laserthermia Systems AB Resolves On A Directed Issue
Brief: Clinical Laserthermia Appoints Katarina Lundqvist As Permanent CFO
Brief: CLS Announces Outcome In Rights Issue Of Units
Brief: CLS Agrees On Top-Down Guarantee For Rights Issue
Brief: CLS Conducts Rights Issue Of SEK 39.5 Million